Connor S, Ghaneh P, Raraty M, Rosso E, Hartley M N, Garvey C, Hughes M, McWilliams R, Evans J, Rowlands P, Sutton R, Neoptolemos J P
Department of Surgery, Royal Liverpool University Hospital, 5th floor UCD Building, Daulby Street, Liverpool L69 3GA, UK.
Br J Surg. 2003 Dec;90(12):1542-8. doi: 10.1002/bjs.4341.
The aim of this study was to identify factors associated with death after surgery in patients with extensive pancreatic necrosis.
Sixty-four patients who underwent pancreatic necrosectomy between 1996 and 2002 were studied.
The median age was 60.5 (95 per cent confidence interval (c.i.) 57 to 64) years and 40 patients (62.5 per cent) were tertiary referrals. The initial median Acute Physiology And Chronic Health Evaluation (APACHE) II score was 9 (95 per cent c.i. 7.9 to 10.1) and there were 21 deaths (32.8 per cent). Twenty-eight patients (43.8 per cent) underwent minimally invasive retroperitoneal pancreatic necrosectomy (MIRP) and the remainder had open pancreatic necrosectomy (OPN); 44 (72.1 per cent) of 61 patients had infected pancreatic necrosis at the time of the first procedure. Seven patients who underwent MIRP died compared with 14 after OPN (P = 0.240). Patients who died were older than those who survived, with higher APACHE II scores at presentation, and before and after surgery (P = 0.001). Survivors had significantly longer times to surgery than those who died (P = 0.038). All 21 patients who died required intensive care compared with 26 of 43 survivors (P < 0.001). Thirty of 36 patients who had the OPN procedure required intensive care compared with only 17 of 28 patients who had MIRP (P = 0.042). Logistic regression analysis showed that only postoperative APACHE II score was an independent predictor of increased mortality (P = 0.031).
Advanced age and increasing APACHE II score, and a need for postoperative intensive care, were the most important predictors of outcome after pancreatic necrosectomy.
本研究旨在确定广泛胰腺坏死患者术后死亡的相关因素。
对1996年至2002年间接受胰腺坏死组织清除术的64例患者进行研究。
中位年龄为60.5岁(95%置信区间57至64岁),40例患者(62.5%)为三级转诊患者。初始急性生理与慢性健康状况评估(APACHE)II评分中位数为9分(95%置信区间7.9至10.1),有21例死亡(32.8%)。28例患者(43.8%)接受了微创腹膜后胰腺坏死组织清除术(MIRP),其余患者接受了开放性胰腺坏死组织清除术(OPN);61例患者中有44例(72.1%)在首次手术时存在感染性胰腺坏死。接受MIRP的7例患者死亡,而接受OPN的患者有14例死亡(P = 0.240)。死亡患者比存活患者年龄更大,术前、术中和术后的APACHE II评分更高(P = 0.001)。存活患者的手术时间明显长于死亡患者(P = 0.038)。所有21例死亡患者均需要重症监护,而43例存活患者中有26例需要(P < 0.001)。接受OPN手术的36例患者中有30例需要重症监护,而接受MIRP的28例患者中只有17例需要(P = 0.042)。逻辑回归分析显示,只有术后APACHE II评分是死亡率增加的独立预测因素(P = 0.031)。
高龄、APACHE II评分增加以及术后需要重症监护是胰腺坏死组织清除术后预后的最重要预测因素。